What's the cause of the slow uptake, even in places like China, which manufactures its own vaccine and where they have a fairly robust system of delivery and procurement, and their levels are very low? We see the uptake load. It's not a matter of pure availability, but also hesitancy or other factors.
Can anyone elaborate on the Chinese situation, where it's almost one-sixth of the population of the world?